Insights

Innovative Diagnostic Platform ActivSignal's proprietary Multiplex Paired-antibody Amplified Detection (MPAD) platform positions it as a cutting-edge provider of protein profiling solutions for diagnostics, offering unique technological advantages that appeal to health biotech companies seeking advanced biomarker detection capabilities.

Growing Market Recognition Receiving a Stage 1 award from a regional biotech funding program highlights the company's validation and potential for growth, presenting opportunities for partners or investors interested in emerging biotech innovations with regional development incentives.

Revenue Potential With an estimated revenue range of 10 to 25 million dollars and recent funding of half a million, ActivSignal is positioned as a mid-stage company with considerable market traction, creating opportunities for collaborations that can accelerate commercialization efforts.

Tech Stack Leverage Utilizing cloud-based services like Google Cloud and modern web technologies signifies operational efficiency and scalability, enabling targeted demonstrations or integrations for biotech clients seeking reliable data infrastructure for diagnostic tools.

Industry Alignment Operating within the competitive biotechnology research space alongside firms like SentinelOne and CrowdStrike, ActivSignal's focus on protein profiling for diagnostics aligns with industry trends towards personalized medicine, creating avenues for joint development or strategic alliances in the biotech ecosystem.

Similar companies to ActivSignal

ActivSignal Tech Stack

ActivSignal uses 8 technology products and services including Google Cloud CDN, WordPress, MySQL, and more. Explore ActivSignal's tech stack below.

  • Google Cloud CDN
    Content Delivery Network
  • WordPress
    Content Management System
  • MySQL
    Database
  • Module Federation
    Development
  • Google Cloud
    Infrastructure As A Service
  • JSON-LD
    Javascript Frameworks
  • WebsiteBuilder
    Page Builders
  • Priority Hints
    Performance

ActivSignal's Email Address Formats

ActivSignal uses at least 1 format(s):
ActivSignal Email FormatsExamplePercentage
FLast@activsignal.comJDoe@activsignal.com
100%

Frequently Asked Questions

Where is ActivSignal's headquarters located?

Minus sign iconPlus sign icon
ActivSignal's main headquarters is located at Natick, Massachusetts United States. The company has employees across 1 continents, including North America.

What is ActivSignal's official website and social media links?

Minus sign iconPlus sign icon
ActivSignal's official website is activsignal.com and has social profiles on LinkedInCrunchbase.

What is ActivSignal's SIC code NAICS code?

Minus sign iconPlus sign icon
ActivSignal's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ActivSignal have currently?

Minus sign iconPlus sign icon
As of April 2026, ActivSignal has approximately 7 employees across 1 continents, including North America. Key team members include Ceo, Co-Founder: M. M.Chief Business Officer: T. P.Chief Scientific Officer, Co-Founder At Activsignal: I. A.. Explore ActivSignal's employee directory with LeadIQ.

What industry does ActivSignal belong to?

Minus sign iconPlus sign icon
ActivSignal operates in the Biotechnology Research industry.

What technology does ActivSignal use?

Minus sign iconPlus sign icon
ActivSignal's tech stack includes Google Cloud CDNWordPressMySQLModule FederationGoogle CloudJSON-LDWebsiteBuilderPriority Hints.

What is ActivSignal's email format?

Minus sign iconPlus sign icon
ActivSignal's email format typically follows the pattern of FLast@activsignal.com. Find more ActivSignal email formats with LeadIQ.

How much funding has ActivSignal raised to date?

Minus sign iconPlus sign icon
As of April 2026, ActivSignal has raised $500K in funding. The last funding round occurred on May 22, 2024 for $500K.

When was ActivSignal founded?

Minus sign iconPlus sign icon
ActivSignal was founded in 2016.

ActivSignal

Biotechnology ResearchMassachusetts, United States2-10 Employees

BlueSCAI™:
Harness the Power of Ultra-Sensitive Protein Profiling in Multiplex
Unlock Critical Protein Biomarkers with Unprecedented Detection and Quantitation with Best-In-Class Platform.

Down to attomolar sensitivity

Ultra-sensitive for detecting the lowest abundance biomarkers.

5 Logs LOD Advantage

Up to 5 logs LOD advantage over leading multiplex proteomics platforms, head-to-head comparison.

BlueSCAI Background Removal

Detects down to <1,000 molecules per target per well, using the same antibody pairs as commercial ELISAs.

Locked-in Specificity

Paired-antibody proximity detection with NGS read-out of ligated DNA barcodes ensures high specificity.

Mechanistic Biology

Biologic perturbation mapping. Map time-resolved pathway responses to stimuli, drugs, and stressors—at high plex, from tiny samples.

Broad Dynamic Range

Measure changes across the biological spectrum. Tunable for optimal NGS read-out.

Multiplex Biomarker Quantification
ActivSignal's BlueSCAI is built on our patented Multiplex Paired-Antibody Amplified Detection (MPAD) technology — a highly specific and sensitive platform for profiling proteins and their modifications in multiplex.
BlueSCAI (Background lowering using Serial Capture, Adapter Insertion) detects protein targets using specific, dual-binding of antibody-pairs, an architecture that increases specificity, an integrated capture-release-recapture mechanism that dramatically lowers background, signal amplification, and specific NGS read-out — with a large and tunable dynamic range.
Highly scalable — from single to tens to hundreds of biomarkers, measured in multiplex from the same small sample with high specificity and sensitivity.

Earlier Detection of Pancreatic Cancer
The PanDx™ assay read-out from the patient sample, across the multiple proteins and other biomarkers in the Panel, provides a "bio-signature" for that individual.
for the detection of early-stage cancer.

Visit our website for more details.

Section iconCompany Overview

Headquarters
Natick, Massachusetts United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
2-10

Section iconFunding & Financials

  • $500K

    ActivSignal has raised a total of $500K of funding over 5 rounds. Their latest funding round was raised on May 22, 2024 in the amount of $500K.

  • $10M$25M

    ActivSignal's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $500K

    ActivSignal has raised a total of $500K of funding over 5 rounds. Their latest funding round was raised on May 22, 2024 in the amount of $500K.

  • $10M$25M

    ActivSignal's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.